Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Market Today: SoftBank exits Nvidia; Ford doubles on EVs
05:33pm, Tuesday, 11'th Nov 2025
Guru Stock PicksJana Partners has made the following transactions:Reduce in MRCY by 16.73%Stock News Airlines caution on lingering flight chaos: United Airlines
49 Wealth Management LLC Sells 3,660 Shares of Merck & Co., Inc. $MRK
05:54am, Tuesday, 11'th Nov 2025
49 Wealth Management LLC lowered its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 56.9% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 2,769 sh
Merck & Co., Inc. (MRK) Shareholder/Analyst Call Transcript
12:21pm, Monday, 10'th Nov 2025
Merck & Co., Inc. ( MRK ) Shareholder/Analyst Call November 9, 2025 7:01 PM EST Company Participants Peter Dannenbaum - Vice President of Investor Relations Dean Li - Executive VP & President of Merck
Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?
10:51am, Monday, 10'th Nov 2025
Merck leans on Keytruda's expanding cancer indications and new SC formulation to sustain growth momentum into 2026 after soft sales in Q3.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck's Enlicitide, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with HeFH in Phase 3 CORALreef HeFH Trial.
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
02:30pm, Saturday, 08'th Nov 2025
Merck said Saturday its new pill — a potential rival to Regeneron and Amgen — lowered stubbornly high cholesterol by almost 60%.
Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
02:30pm, Saturday, 08'th Nov 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial.
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
10:00am, Friday, 07'th Nov 2025
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 Dirt Cheap Stocks to Buy With $1,000 Right Now
07:15am, Friday, 07'th Nov 2025
Pharmaceutical giant Merck has been prepping for the end of exclusivity for its leading drug. Verizon may not offer much in the way of growth, but it more than makes up for it with income.
Why Merck Is Sinking This Week
02:46pm, Tuesday, 04'th Nov 2025
Sales of blockbuster drug Keytruda missed expectations. The drug's patents will begin to expire in 2028.
Why Merck (MRK) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 04'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merck and Blackstone enter research agreement to develop cancer therapy for $700 million
07:00am, Tuesday, 04'th Nov 2025
Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy.
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
06:50am, Tuesday, 04'th Nov 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company has entered into an agreement to receive funds managed by Black
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the company, through a subsidiary (Prometheus BioSciences), has reached an
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
04:30am, Tuesday, 04'th Nov 2025
Verizon has a 7% yield and is a top player in the telecom space. Chevron has a 4.4% yield and is one of the largest integrated energy companies on the planet.
